# EDGAR Filing Document

**Accession Number:** 0001976695
**File Stem:** 0001493152-26-008632
**Filing Date:** 2026-3
**Character Count:** 73701
**Document Hash:** e817d08cb712ff085df055e2f1c09262
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001493152-26-008632.hdr.sgml**: 20260303

**ACCESSION NUMBER**: 0001493152-26-008632

**CONFORMED SUBMISSION TYPE**: S-8

**PUBLIC DOCUMENT COUNT**: 22

**FILED AS OF DATE**: 20260303

**DATE AS OF CHANGE**: 20260303

**EFFECTIVENESS DATE**: 20260303

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Mobile-health Network Solutions
- **CENTRAL INDEX KEY:** 0001976695
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-PREPACKAGED SOFTWARE [7372]
- **ORGANIZATION NAME:** 06 Technology
- **EIN:** 000000000
- **STATE OF INCORPORATION:** E9
- **FISCAL YEAR END:** 0630

**FILING VALUES:**
- **FORM TYPE:** S-8
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-293953
- **FILM NUMBER:** 26710962

**BUSINESS ADDRESS:**
- **STREET 1:** CRICKET SQUARE, HUTCHINS DRIVE,
- **STREET 2:** P.O. BOX 2681, GRAND CAYMAN, KY1-1111,
- **CITY:** CAYMAN ISLANDS
- **STATE:** E9
- **ZIP:** 000000
- **BUSINESS PHONE:** 65 6222 5223

**MAIL ADDRESS:**
- **STREET 1:** 2 VENTURE DR,
- **STREET 2:** #07-06 VISION EXCHANGE,
- **CITY:** SINGAPORE
- **STATE:** U0
- **ZIP:** 608526

**As filed with the Securities and Exchange Commission on March 3, 2026**

**Registration No. 333-**

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON, D.C. 20549**

**FORM S-8**

**REGISTRATION STATEMENT**

***UNDER***

***THE SECURITIES ACT OF 1933***

**MOBILE-HEALTH NETWORK SOLUTIONS**

**(Exact Name of Registrant as Specified in Its Charter)**

---

| | |
|:---|:---|
| **Cayman Islands** | **Not Applicable** |
| **(State or Other Jurisdiction of**<br> **Incorporation or Organization)** | **(I.R.S. Employer**<br> **Identification No.)** |

---

**2 Venture Drive, #07-06/07 Vision Exchange**

**Singapore 608526**

**+65 6222 5223**

**(Address of Principal Executive Offices, Including Zip Code)**

**MHNS Employee Incentive Plan** 

**(Full Title of the Plan)**

**Cogency Global Inc.**

**122 East 42nd Street, 18th Floor**

**New York, NY 10168**

**(212) 947-7200**

**(Name, address, including zip code, and telephone number, including area code, of agent for service)**

**Copies to:**

**Lawrence S. Venick, Esq.**

**Loeb & Loeb LLP**

**10100 Santa Monica Boulevard** **<br> Suite 2200<br> Los Angeles, CA 90067 <br> Telephone: +1-310-728-5129**

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ <br> Non-accelerated filer ☒ Smaller reporting company ☒ <br> Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

**EXPLANATORY NOTE**

This Registration Statement registers 478,050 additional Class A ordinary shares, par value $0.00016 per share (the "Class A Ordinary Share(s)") and 43,783 Class B ordinary shares, par value $0.00016 per share (the "Class B Ordinary Share(s)"), of Mobile-health Network Solutions (the "Registrant") under the Registrant's Employee Incentive Plan (the "Plan"), representing 478,050 Class A Ordinary Shares and 43,783 Class B Ordinary Shares reserved for issuance under the Plan, as amended with effect from February 6, 2026. The description of the Class A Ordinary Shares and Class B Ordinary Shares set forth under the heading "Description of Share Capital and Governing Documents " in the Registrant's prospectus that constitutes part of the Registration Statement on Form F-1 (File No. 333-277254) initially filed publicly by the Registrant with the U.S. Securities and Exchange Commission on February 22, 2024, as subsequently amended and supplemented from time to time thereafter, including any form of prospectus contained therein filed pursuant to Rule 424(b) under the Securities Act of 1933, as amended, is incorporated herein by reference.

**PART I**

**INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS**

The documents containing the information specified in Item 1 and Item 2 of Part I of Form S-8 will be sent or given to participants as specified by Rule 428(b)(1) under the Securities Act. In accordance with the rules and regulations of the Securities and Exchange Commission (the "Commission") and the instructions to Form S-8, such documents are not being filed with the Commission either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act.

**PART II**

**INFORMATION REQUIRED IN THE REGISTRATION STATEMENT**

**Item 3. Incorporation of Documents by Reference.**

The documents listed below have been filed with the U.S. Securities and Exchange Commission (the "Commission") by the Registrant and are incorporated herein by reference to the extent not superseded by documents subsequently filed:

(1) The
 Registrant's prospectus dated September 9, 2025 filed pursuant to Rule [424(b)(3)](https://www.sec.gov/Archives/edgar/data/1976695/000149315225012947/form424b3.htm) with the Commission on September 10, 2025;

&nbsp;&nbsp;&nbsp;&nbsp;(2) The
 Registrant's current reports on <u>Form 6-K</u> furnished to the Commission on [June 6, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000164117225013933/form6-k.htm) , [June 6, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000164117225013932/form6-k.htm) , [June 16, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000164117225015142/form6-k.htm) , [July 17, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000164117225020013/form6-k.htm) , [August 21, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000149315225012205/form6-k.htm) , [August 25, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000149315225012293/form6-k.htm) , [September 11, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000149315225013053/form6-k.htm) , [September 12, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000149315225013132/form6-k.htm) , [September 25, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000149315225014948/form6-k.htm) , [September 26, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000149315225015049/form6-k.htm) , [October 31, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000149315225020400/form6-k.htm) , [November 20, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000149315225024357/form6-k.htm) , and [January 13, 2026](https://www.sec.gov/Archives/edgar/data/1976695/000149315226001937/form6-k.htm) ;

(3) The Registrant's annual report on [Form 20-F](https://www.sec.gov/Archives/edgar/data/1976695/000149315225020325/form20-f.htm) furnished to the Commission on October 31, 2025;

(4) The
 Registrant's registration statement on Form F-1 furnished to the Commission on [March 21, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000149315225011165/formf-1.htm) (and the amendment filed on [March 28, 2025](https://www.sec.gov/Archives/edgar/data/1976695/000164117225001031/formf-1a.htm)); and

(5) The
 description of ordinary shares contained in the Registrant's Registration Statement on [Form 8-A](https://www.sec.gov/Archives/edgar/data/1976695/000149315224011100/form8-a12b.htm) filed with the Commission pursuant
 to Section 12 of the Exchange Act, on March 25, 2024 and all other amendments and reports filed for the purpose of updating such
 description.

All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act subsequent to the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement which indicates that all securities offered have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference in this Registration Statement and to be a part hereof from the date of the filing of such documents. The Registrant is not incorporating by reference any document or portion thereof, whether specifically listed above or to be filed in the future, that is not deemed "filed" with the Commission.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for the purposes of this Registration Statement to the extent that a statement contained herein (or in any other subsequently filed document which also is incorporated or deemed to be incorporated by reference herein) modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

**Item 4. Description of Securities.**

Not applicable.

**Item 5. Interests of Named Experts and Counsel.**

Not applicable.

**Item 6. Indemnification of Directors and Officers.**

The Cayman Islands laws do not limit the extent to which a company's memorandum and articles of association may provide for indemnification of directors and officers, save to the extent any such provision may be held by the Cayman Islands courts to be contrary to public policy, for example, where a provision purports to provide indemnification against the consequences of committing a crime. Our memorandum and articles of association provide that, to the extent permitted by law, we shall indemnify each existing or former Director (including alternate Director), secretary and other officer of our Company (but not including the Company's auditors) against:

&nbsp;&nbsp;&nbsp;&nbsp;(a) all
 actions, proceedings, costs, charges, expenses, losses, damages or liabilities incurred or sustained by the existing or former Director
 (including alternate Director), secretary or officer in or about the conduct of the Registrant's business or affairs or in
 the execution or discharge of the existing or former Director's (including alternate Director's), secretary's or
 officer's duties, powers, authorities or discretions (including as a result of any mistake of judgment); and

&nbsp;&nbsp;&nbsp;&nbsp;(b) without
 limitation to paragraph (a), all costs, expenses (including reasonable attorneys' fees), losses or liabilities incurred by
 the existing or former Director (including alternate Director), secretary or officer in defending (whether successfully or otherwise)
 any civil proceedings concerning the Registrant or its affairs in any court, whether in the Cayman Islands or elsewhere.

No such existing or former Director (including alternate Director), secretary or officer, however, shall be indemnified in respect of any matter arising out of his own dishonesty, wilful default or fraud.

To the extent permitted by the Companies Act (Revised) of the Cayman Islands ("Cayman Companies Act"), the Registrant may make a payment, or agree to make a payment, whether by way of advance, loan or otherwise, for any legal costs incurred by an existing or former Director (including alternate Director), secretary or officer of the Registrant in respect of any matter identified above on condition that the Director (including alternate Director), secretary or officer must repay the amount paid by the Registrant to the extent that we are ultimately found not liable to indemnify the Director (including alternate Director), secretary or that officer for those legal costs.

We may, to the extent permitted by the Cayman Companies Act, pay or agree to pay, a premium in respect of a contract insuring each of the following persons against risks determined by the Directors, other than liability arising out of that person's own dishonesty:

&nbsp;&nbsp;&nbsp;&nbsp;(a) an
 existing or former Director (including alternate Director), secretary or officer of (i) the Registrant; (ii) a company which is or
 was a subsidiary of the Registrant; (iii) a company in which the Registrant has or had an interest (whether direct or indirect);
 and

&nbsp;&nbsp;&nbsp;&nbsp;(b) a
 trustee of an employee or retirement benefits scheme or other trust in which any of the persons referred to in paragraph (a) is or
 was interested.

We have insurance policies under which, subject to the limitations of the policies, coverage is provided to our directors and officers against loss arising from claims made by reason of breach of fiduciary duty or other wrongful acts as a director or officer, including claims relating to public securities matters, and to us with respect to payments that may be made by us to these officers and directors pursuant to our indemnification obligations or otherwise as a matter of law.

At present, we are not aware of any pending litigation or proceeding involving any person who is or was one of our directors, officers, employees or other agents or is or was serving at our request as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, for which indemnification is sought, and we are not aware of any threatened litigation that may result in claims for indemnification.

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling us pursuant to the foregoing provisions, we have been informed that in the opinion of the Securities and Exchange Commission (the "Commission") such indemnification is against public policy as expressed in the Securities Act and is theretofore unenforceable.

**Item 7. Exemption From Registration Claimed.**

Not applicable.

**Item 8. Exhibits.**

---

| | |
|:---|:---|
| **Exhibit Number** | **Description** |
| 4.1\*\* | [Amended and Restated Memorandum and Articles of Association of the Registrant, as currently in effect (incorporated by reference to Exhibit 3.1 of Amendment No. 1 to the Registration Statement on Form F-1 (File No. 333-286026) filed with the Securities and Exchange Commission on March 28, 2025)](https://www.sec.gov/Archives/edgar/data/1976695/000149315224007522/ex3-1.htm) |
| 4.2\*\* | [Specimen certificate evidencing ordinary shares (incorporated by reference to Exhibit 4.1 to our Amendment no. 1 to Registration Statement on Form F-1 (File No. 333-286026) filed with the Securities and Exchange Commission on March 28, 2025)](https://www.sec.gov/Archives/edgar/data/1976695/000149315224008984/ex4-1.htm) |
| 5.1\* | [Opinion of Harney Westwood & Riegels](ex5-1.htm) |
| 23.1\* | [Consent of Harney Westwood & Riegels (included in Exhibit 5.1).](ex5-1.htm) |
| 23.2\* | [Consent of JWF Assurance PAC](ex23-2.htm) |
| 23.3\* | [Consent of Simon & Edward, LLP](ex23-3.htm) |
| 24.1 | [Power of Attorney (included on the signature page to this Registration Statement).](#Y-001) |
| 99.1\* | [MHNS Employee Share Incentive Plan](ex99-1.htm) |
| 107 \* | [Filing Fee Table](ex107.htm) |

---

**\*** **Filed herewith.**

**\*\*** **Previously filed.**

**Item 9. Undertakings.**

&nbsp;&nbsp;&nbsp;&nbsp;(a) The
 undersigned Registrant hereby undertakes:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) To
 file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) To
 include any prospectus required by Section 10(a)(3) of the Securities Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) To
 reflect in the prospectus any facts or events arising after the effective date of this Registration Statement (or the most recent
 post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set
 forth in this Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if
 the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end
 of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b)
 if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set
 forth in the "Calculation of Registration Fee" table in the effective registration statement; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) To
 include any material information with respect to the plan of distribution not previously disclosed in this Registration Statement
 or any material change to such information in this Registration Statement;

*Provided, however*, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(2) That,
 for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a
 new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be
 deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(3) To
 remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the
 termination of the offering.

&nbsp;&nbsp;&nbsp;&nbsp;(b) The
 undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of
 the Registrant's annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each
 filing of an employee benefit plan's annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference
 in this Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and
 the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

&nbsp;&nbsp;&nbsp;&nbsp;(c) Insofar
 as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons
 of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the
 Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In
 the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred
 or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding)
 is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will,
 unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction
 the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed
 by the final adjudication of such issue.

**<u>SIGNATURES</u>**

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Singapore, on March 3, 2026.

---

| | |
|:---|:---|
| **MOBILE-HEALTH NETWORK SOLUTIONS** | **MOBILE-HEALTH NETWORK SOLUTIONS** |
| By: | */s/ Siaw Tung Yeng* |
| Name: | Siaw Tung Yeng |
| Title: | Co-Chief Executive Officer and Director |

---

**<u>SIGNATURES AND POWERS OF ATTORNEY</u>**

Each of the undersigned officers and directors of the Registrant hereby severally constitutes and Guohua Huang, acting alone, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and re-substitution, for him or her and in his or her name, place and stead, and in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement and any subsequent registration statement filed pursuant to Rule 462 under the Securities Act, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Commission and any applicable securities exchange or securities self-regulatory body, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or either of them individually, or their or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

---

| | | |
|:---|:---|:---|
| **Name** | **Title** | **Date** |
| */s/ Siaw Tung Yeng* | Co-Chief Executive Officer and Director | March 3, 2026 |
| Siaw Tung Yeng | (*Principal Executive Officer*) |  |
| */s/ Teoh Pui Pui* | Co-Chief Executive Officer/Chief Operating Officer/Chairwoman of the Board/Director | March 3, 2026 |
| Teoh Pui Pui | (*Principal Executive Officer*) |  |
| */s/ Leong Aik Huat* | Chief Financial Officer | March 3, 2026 |
| Leong Aik Huat | (*Principal Financial Officer and Accounting Officer*) |  |
| */s/ Ho Hin Yip* | Independent Director | March 3, 2026 |
| Ho Hin Yip |  |  |
| */s/ Tam Kim Han Raymond* | Independent Director | March 3, 2026 |
| Tam Kim Han Raymond |  |  |
| */s/ Gabe Rijpma* | Independent Director | March 3, 2026 |
| Gabe Rijpma |  |  |

---

**Authorized U.S. Representative**

Pursuant to the Securities Act of 1933 as amended, the undersigned, the duly authorized representative in the United States of America, has signed this registration statement thereto in New York on March 3, 2026.

---

| | |
|:---|:---|
| COGENCY GLOBAL INC. | COGENCY GLOBAL INC. |
| By: | */s/ Colleen A. De Vries* |
| Name: | Colleen A. De Vries |
| Title: | Senior Vice President |

---

## Exhibit 5.1

**Exhibit 5.1**

---

| | |
|:---|:---|
| ![](ex5-1_001.jpg) | Harney Westwood & Riegels Singapore LLP<br> 138 Market Street<br> #24-04 CapitaGreen<br> Singapore 048946<br> Tel: +65 6800 9830<br> Fax: +65 6800 9831 |

---

3 March 2026

lishi.fong@harneys.com

+65 6800 9833

059929.0001/LZF

**Mobile-health Network Solutions**

Harneys Fiduciary (Cayman) Limited

4th Floor, Harbour Place, 103 South Church Street

PO Box 10240

Grand Cayman KY1-1002

Cayman Islands

Dear Sir or Madam

**Mobile-health Network Solutions** (the ***Company***)

We are lawyers qualified to practise in the Cayman Islands and have acted as Cayman Islands legal advisers to the Company in connection with the Company's registration statement on Form S-8, including all amendments or supplements thereto (the ***Registration Statement***), to be filed on or about the date of this opinion with the Securities and Exchange Commission (the ***Commission***) under the United States Securities Act of 1933, as amended (the ***Securities Act***), relating to the Company's Class A Ordinary Shares of nominal or par value of US$0.00016 per share reserved for issuance under the Company's amended and restated MHNS Employee Incentive Plan (the ***Plan***) approved pursuant to the Resolutions (as defined in Schedule 1) (the ***Shares***).

We are furnishing this opinion as Exhibit 5.1 to the Registration Statement.

For the purposes of giving this opinion, we have examined the Documents (as defined in Schedule 1). We have not examined any other documents, official or corporate records or external or internal registers and have not undertaken or been instructed to undertake any further enquiry or due diligence in relation to the transaction which is the subject of this opinion.

In giving this opinion we have relied upon the assumptions set out in Schedule 2 which we have not independently verified.

Based solely upon the foregoing examinations and assumptions and upon such searches as we have conducted and having regard to legal considerations which we deem relevant, and subject to the qualifications set out in Schedule 3, we are of the opinion that under the laws of the Cayman Islands:

---

| | |
|:---|:---|
| 1 | **Existence and Good Standing.** The Company has been duly incorporated as an exempted company with limited liability and is validly existing and in good standing under the laws of the Cayman Islands. |

---

---

| | |
|:---|:---|
| Jersey legal services are provided through a referral arrangement with Harneys (Jersey) which is an independently owned and controlled Jersey law firm. | Anguilla \| Bermuda \| British Virgin Islands <br> Cayman Islands \| Cyprus \| Dubai \| Hong Kong \| Jersey<br> London \| Luxembourg \| Shanghai \| Singapore |
| Registered in Singapore with limited liability (T13LL2450G). | harneys.com |

---

---

| | |
|:---|:---|
| 2 | **Authorised Share Capital.** Based on our review of the M&A (as defined in Schedule 1), the authorised share capital of the Company is US$50,000 divided into 312,500,000 Ordinary Shares of nominal or par value of US$0.00016 each, comprising (a) 156,250,000 Class A Ordinary Shares of nominal or par value US$0.00016 each and (b) 156,250,000 Class B Ordinary Shares of nominal or par value of US$0.00016 each. |

---

---

| | |
|:---|:---|
| 3 | **Valid Issuance of Shares.** |

---

The Shares to be issued by the Company as contemplated by the Registration Statement have been duly authorised and, when allotted, issued and fully paid for in accordance with the Resolutions, and when the name of the shareholder is entered in the register of members of the Company, the Shares will be validly issued, allotted and fully paid and there will be no further obligation on the holder of any of the Shares to make any further payment to the Company in respect of such Shares.

---

| | |
|:---|:---|
| 4 | **MHNS Employee Incentive Plan.** The Plan does not contravene the Companies Act (as revised) of the Cayman Islands (the ***Companies Act***). |

---

This opinion is confined to the matters expressly opined on herein and given on the basis of the laws of the Cayman Islands as they are in force and applied by the Cayman Islands courts at the date of this opinion. We have made no investigation of, and express no opinion on, the laws of any other jurisdiction. Except as specifically stated herein, we express no opinion as to matters of fact.

In connection with the above opinion, we hereby consent to the filing of this opinion as an exhibit to the Registration Statement. In giving such consent, we do not thereby admit that we come within the category of persons whose consent is required under Section 7 of the Securities Act, as amended, or the Rules and Regulations of the Commission thereunder.

This opinion is limited to the matters referred to herein and shall not be construed as extending to any other matter or document not referred to herein.

This opinion shall be construed in accordance with the laws of the Cayman Islands.

Yours faithfully

![](ex5-1_002.jpg)

**Harney Westwood & Riegels Singapore LLP**

**SCHEDULE 1**

List of Documents and Records Examined

1 the Certificate of Incorporation of the Company dated 28 July 2016;

---

| | |
|:---|:---|
| 2 | the amended and restated memorandum and articles of association of the Company as adopted with effect from 23 September 2025 by a special resolution passed on 11 September 2025 (the ***M&A***); |

---

3 the register of directors and officers of the Company filed with the Registrar of Companies in the Cayman Islands on 16 October 2024;

4 a certificate of good standing dated 5 February 2026 in respect of the Company, issued by the Registrar of Companies in the Cayman Islands;

---

| | |
|:---|:---|
| 5 | the search results in relation to the Company obtained from the Cayman Islands Online Registry Information System (CORIS), the Cayman Islands' General Registry's online database, on 3 March 2026; |

---

---

| | |
|:---|:---|
| 6 | a copy of the written resolutions of the board of directors of the Company dated 6 February 2026 and 24 February 2026 and the unanimous written resolutions of the employee incentive plan committee of the Company dated 6 February 2026 (the ***Resolutions***), |

---

copies of 1 to 6 above have been provided to us by the Company and the Company's registered office in the Cayman Islands (together the ***Corporate Documents***),

7 the Registration Statement; and

---

| | |
|:---|:---|
| 8 | the Plan, approved by the Resolutions (together with the Registration Statement, the ***Transaction Documents***), |

---

the Corporate Documents and the Transaction Documents are collectively referred to in this opinion as the ***Documents***.

**SCHEDULE 2**

Assumptions

---

| | |
|:---|:---|
| 1 | **Validity under Foreign Laws.** That (i) all formalities required under any applicable laws (other than the laws of the Cayman Islands) have been complied with; and (ii) no other matters arising under any foreign law will affect the views expressed in this opinion. |

---

---

| | |
|:---|:---|
| 2 | **Memorandum and Articles.** The M&A remain in full force and effect and are otherwise unamended. The M&A will be the memorandum and articles of association of the Company in effect at the time of the issue of the Shares. |

---

---

| | |
|:---|:---|
| 3 | **Choice of Laws.** The choice of the laws of Singapore selected to govern the Plan has been made in good faith and will be regarded as a valid and binding selection which will be upheld in the courts of that jurisdiction and all other relevant jurisdictions (other than the Cayman Islands) and the entry into and performance of the Plan will not cause any of the parties thereto to be in breach of any agreement or undertaking. |

---

---

| | |
|:---|:---|
| 4 | **Directors.** The board of directors of the Company considers the transactions contemplated by the Transaction Documents to be in the best interests of the Company and no director has (i) a financial interest in a party to or in the transactions contemplated by the Transaction Documents or (ii) other relationship to a party to the transactions contemplated by the Transaction Documents which has not been properly disclosed in the Resolutions. |

---

---

| | |
|:---|:---|
| 5 | **Conditions.** All conditions to the obligations of the parties to the Plan will be satisfied or duly waived prior to the issue and sale of the Shares and there will be no breach of the terms of the Plan. |

---

---

| | |
|:---|:---|
| 6 | **Authenticity of Documents.** All original Documents are authentic, all signatures, initials and seals are genuine, all copies of Documents are true and correct copies and the Transaction Documents conform in every material respect to the latest drafts of the same produced to us and, where the Transaction Documents have been provided to us in successive drafts marked-up to indicate changes to such documents, all such changes have been so indicated. |

---

---

| | |
|:---|:---|
| 7 | **Corporate Documents.** All matters required by law to be recorded in the Corporate Documents are so recorded, and all corporate minutes, resolutions, certificates, documents and records which we have reviewed are accurate and complete, and all facts expressed in or implied thereby are accurate and complete. |

---

---

| | |
|:---|:---|
| 8 | **No Steps to Wind-up**. The directors and shareholders of the Company have not taken any steps to have the Company struck off or placed in liquidation, no steps have been taken to wind up the Company and no receiver has been appointed over any of the property or assets of the Company. |

---

---

| | |
|:---|:---|
| 9 | **Resolutions**. The Resolutions have been duly executed (and where by a corporate entity such execution has been duly authorised if so required) by or on behalf of each director or shareholder (as the case may be), and the signatures and initials thereon are those of a person or persons in whose name the Resolutions have been expressed to be signed. The Resolutions remain in full force and effect. |

---

---

| | |
|:---|:---|
| 10 | **Unseen Documents.** Save for the Documents provided to us there are no resolutions, agreements, documents or arrangements which materially affect, amend or vary the transactions envisaged in the Documents. There is no contractual prohibition (other than as arising under Cayman Islands law) binding on the Company prohibiting it from issuing and allotting the Shares. |

---

---

| | |
|:---|:---|
| 11 | **Proceeds of Crime.** No monies paid to or for the account of any party under the Transaction Documents represent or will represent criminal property or terrorist property (as defined in the Proceeds of Crime Act (2025 Revision) and the Terrorism Act (2018 Revision), respectively). |

---

---

| | |
|:---|:---|
| 12 | **Exercise.** At the time of the issuance of the Shares in accordance with the Plan (the ***Issuance***): |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) the
 Companies Act will not have changed in such a way as to materially impact the Issuance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) the
 Company will have sufficient authorised but unallotted and unissued shares, in each case
 to effect the Issuance in accordance with the M&A and the Companies Act;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) the
 Company will be able to pay its debts as they fall due in the ordinary course of business
 immediately following the Issuance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) the
 Company will have shares in issue immediately prior to the Issuance other than the Shares
 to be issued;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) all
 the considerations will have been fully paid and without obligation of the holder to make
 further payment to the Company in respect of the Issuance;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) the
 Company will not have been struck off or placed in liquidation;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) the
 issue price for the Shares to be issued on the Issuance will not be less than the par value
 of such Shares; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) the
 provisions of the M&A relating to the Issuance will not have been altered, amended and
 restated.

**SCHEDULE 3**

Qualifications

---

| | |
|:---|:---|
| 1 | **Foreign Statutes.** We express no opinion in relation to provisions making reference to foreign statutes in the Transaction Documents. |

---

---

| | |
|:---|:---|
| 2 | **Stamp Duty.** Cayman Islands stamp duty may be payable if the original Transaction Documents are executed in, brought to, or produced before a court of, the Cayman Islands. |

---

---

| | |
|:---|:---|
| 3 | **Good Standing.** The Company shall be deemed to be in good standing at any time if all fees (including annual filing fees) and penalties under the Companies Act have been paid and the Registrar of Companies in the Cayman Islands has no knowledge that the Company is in default under the Companies Act. |

---

---

| | |
|:---|:---|
| 4 | **Conflict of Laws.** An expression of an opinion on a matter of Cayman Islands law in relation to a particular issue in this opinion should not necessarily be construed to imply that the Cayman Islands courts would treat Cayman Islands law as the proper law to determine that issue under its conflict of laws rules. |

---

---

| | |
|:---|:---|
| 5 | **Economic Substance**. We have undertaken no enquiry and express no view as to the compliance of the Company with the International Tax Co-operation (Economic Substance) Act (2021 Revision). |

---

## Exhibit 23.2

**Exhibit 23.2**

---

| | |
|:---|:---|
| ![](ex23-2_001.jpg) | ![](ex23-2_002.jpg) |

---

**<u>CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</u>**

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated October 31, 2025 relating to the consolidated financial statements appearing in the Annual Report on Form 20-F of Mobile-health Network Solutions and Its Subsidiaries for the year ended June 30, 2025. We also consent to the reference to us under the heading "Experts" in such Registration Statement.

/s/ JWF Assurance PAC

JWF Assurance PAC

Singapore

March 3, 2026

Page **1** of **1**<br>

## Exhibit 23.3

**Exhibit 23.3**

![](ex23-3_001.jpg)

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

Mobile-Health Network Solutions

We hereby consent to the incorporation by reference of our report in this Form S-8 of Mobile-Health Network Solutions (the "Company"), to be filed on or about March 3, 2026, of our report dated October 27, 2023 and March 6, 2024, with respect to our audit of the Company's consolidated financial statements as of June 30, 2023, and 2022 and for the years then ended.

![](ex23-3_002.jpg)

Rowland Heights, California

March 3, 2026

## Exhibit 99.1

**Exhibit 99.1**

**RULES OF THE MHNS EMPLOYEE INCENTIVE PLAN**

**1.** **NAME OF THE PLAN** 

The "**MHNS Employee Incentive Plan**" (hereinafter referred to as the "**Plan**") has been established by Mobile-health Network Solutions, an exempted company incorporated in the Cayman Islands with limited liability with registration number 313720 (the "**Company**").

**2.** **OBJECTIVES OF THE PLAN** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.1. The
 Plan will give employees of the Company and/or any of its subsidiaries, including all directors
 of the Company and its subsidiaries, as well as advisors, consultants and directors engaged
 by the Company and/or any of its subsidiaries an opportunity to have a personal equity interest
 in the Company and will help to achieve the following objectives:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) provide
 a wealth creation opportunity for the employees, advisors, consultants and directors in line
 with value creation for the Company;

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) drive
 retention of employees, advisors, consultants and directors for their continued association
 with the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) motivate
 employees, advisors, consultants and directors by rewarding high performance.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.2. The
 Plan will align the interest of the Participants (as defined below) with that of the Company
 and provides for an incentive mechanism that rewards ownership and extraordinary contribution.

**3.** **ADMINISTRATION OF THE PLAN** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.1. **Implementation.** The Plan has been approved at a meeting of the board of directors of the Company (the
 "**Board**") on 23 February 2023 and by the unanimous written resolutions
 of the Board passed on 27 March 2023, and was subsequently amended by written resolutions
 of the Employee Incentive Plan Committee of the Company (the "**Committee** ")
 passed on 21 September 2023, 18 September 2024, 3 June 2025 and 6 February 2026.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.2. **Administration.** The Plan will be administered by the Committee in its sole and absolute discretion with
 such powers and duties as are conferred on it by the Board from time to time. Subject to
 the provisions of the Plan and compliance with the applicable laws, the Committee shall have
 the power, from time to time, to make and vary such regulations for the implementation and
 administration of this Plan and to make all determinations under the Plan as it in its absolute
 discretion deems fit, including but not limited to (i) any modification and/or alterations
 on the type of Awards to be granted, (ii) the size of the Plan and the classes of shares
 to be included in the Plan, (iii) determining which employees, directors, advisors, or consultants
 shall received an Award in the Plan, (iv) term of any Awards, (v) the date(s) on which an
 Award vests, (vi) the terms and conditions of an Award, (vii) the number of Options or Restricted
 Shares (as defined below) which may be granted under an Award, (viii) performance goals applicable
 to any Awards, and (ix) the waiver of any restrictions or performance goals in respect of
 an Award. Any matter pertaining or pursuant to this Plan and any dispute as to the interpretation
 of this Plan or any rule, regulation, procedure thereunder or as to any rights under this
 Plan, shall be determined by the Committee and such decision shall be final and binding.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.3. **Directors' Participation.** Any director, employee or other person participating in this Plan who
 is a member of the Committee shall not be involved in the Committee's deliberations
 in respect of any Awards (as defined below) granted to him.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.4. **Determination of the Committee to be final.** Any decision or determination of the Committee made pursuant
 to any provision of the Plan (other than a matter to be certified by the auditors of the
 Company) shall be final, binding and conclusive (including for the avoidance of doubt, any
 decisions pertaining to disputes as to the interpretation of the Plan or any rule, regulation
 or procedure hereunder or as to any rights under the Plan). The Committee shall not be required
 to furnish any reasons for any decision or determination made by it.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.5. **Duration of the Plan.** The Plan may be terminated at any time by the Committee or, at the discretion
 of the Committee, by ordinary resolution of the Company, and if the Plan is so terminated,
 no further Awards shall be offered hereunder.

**4.** **ELIGIBILITY** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.1. **Eligibility.** The Committee shall in its sole and absolute discretion determine if a person is eligible
 to participate in the Plan, taking into consideration, among other things, role, seniority,
 length of service, performance history and potential contribution to the Company and/or any
 of its subsidiaries, and such person shall at least be a confirmed employee of the Company
 and/or any of its subsidiaries, or an advisor, consultant or director of the Company and/or
 any of its subsidiaries, and who have attained the age of twenty-one (21) years ()"**Participant** ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.2. **Grant Frequency.** The Committee may at any time grant Awards to Participants, as the Committee
 may select based on the eligibility of the Participants under Rule 4.1 above, subject only
 to such restrictions as may be provided under any applicable law.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.3. **Number of Awards.** The number of Awards to be granted to a Participant in accordance with the
 Plan shall be determined at the absolute discretion of the Committee, which shall take into
 account such criteria as it considers fit, including (but not limited to) his rank, job performance,
 years of service and potential for future development, his contribution to the success and
 development of the Company, the past performance of the Participant and any other key performance
 indicators.

**5.** **SIZE OF PLAN** 

The aggregate number of Class A Shares of a nominal or par value of US$0.00016 each and Class B Shares of a nominal or par value of US$0.00016 each in the capital of the Company (together, the "**Shares**") which may be issued each financial year pursuant to Awards granted under this Plan shall not exceed fifteen per cent. (15%) of the total issued Class A Shares and Class B Shares of a nominal or par value of US$0.00016 each in the capital of the Company ("**Issued Shares**"). Each Class A Share is entitled for one vote and each Class B Share is entitled for ten votes.

**6.** **GRANT OF AWARDS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.1. **Grant of Awards.** Under the Plan, the Company may grant Options (as defined below) or Restricted
 Shares (as defined below) ()"**Awards** "). An Award may be granted at any time
 as may be determined by the Committee in its sole and absolute discretion and may be granted
 subject to such conditions as may be determined by the Committee in its absolute discretion.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.2. **Letter of Offer.** As soon as reasonably practicable after the grant of an Award, the Committee
 shall send to each Participant a letter of offer ()"**Letter of Offer**") which
 shall be in or substantially in the form set out in Schedule A-1, subject to such modifications
 as the Committee may determine from time to time.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.3. **Acceptance of an Award.** The grant of an Award under this Rule 6 shall be accepted by the Participant
 within the date stipulated in the acceptance form, which shall be in or substantially in
 the form set out in Schedule A-2 (the "**Acceptance Form** "), subject to such
 modifications as the Committee may determine from time to time, by completing, signing and
 returning the Acceptance Form. If a grant of an Award is not accepted in the manner as provided
 in this Rule 6, such offer shall, upon the expiry of the date stipulated, automatically lapse
 and become null, void and of no effect.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.4. **Awards are Personal.** An Award shall be personal to the Participant to whom it is granted and,
 prior to the allotment and/or transfer to the Participant of the Shares to which the Award
 relates, shall not be transferred (other than to a Participant's personal representative
 on the death of that Participant), charged, assigned, pledged or otherwise disposed of, in
 whole or in part, except with the prior approval of the Committee. If a Participant shall
 do, suffer or permit any such act or thing as a result of which he would or might be deprived
 of any rights under an Award without the prior approval of the Committee, that Award shall
 immediately lapse.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.5. **Contravention of any Applicable Law.** In the event that the grant of an Award results in a contravention
 of any applicable law, subsidiary legislation or other regulation, such grant shall be null,
 void and of no effect and the relevant Participant shall have no claim whatsoever against
 the Company.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.6. **Lapsing of Awards.** An Award shall, to the extent unexercised or unvested, immediately lapse and
 become null and void, without any claim whatsoever against the Company and the Participant
 shall have no further rights in respect thereof:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) if
 a Participant ceases to be employed by the Company and/or any of its subsidiaries, or ceases
 to be engaged by the Company and/or any of its subsidiaries as an advisor, consultant or
 director (as the case may be);

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) upon
 the bankruptcy of the Participant or the happening of any event which results in his being
 deprived of the legal and beneficial ownership of such Option; or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) in
 the event of misconduct or negligence on the part of the Participant, as determined by the
 Committee in its discretion,

(collectively, the "**Lapsing Events**").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.7. **Liquidity Event.** In addition and notwithstanding any other Rule of this Plan, in the event a notice
 is given by the Company to its members to convene a general meeting for the purposes of considering
 and, if thought fit, approving a resolution to voluntarily wind-up the Company ()"**Liquidity Event** "), the Company shall on the same date as or soon after it despatches such
 notice to each member of the Company give notice thereof to all Participants ()"**Liquidity Notice**") (together with a notice of the existence of the provision of this Rule
 6.7) and thereupon, each Participant (or his personal representative) shall be entitled to
 exercise all or any of his Options at any time not later than two business days prior to
 the proposed general meeting of the Company by giving notice in writing to the Company, accompanied
 by a remittance for the full amount of the aggregate Exercise Price (as defined below) for
 the Shares in respect of which the notice is given whereupon the Company shall as soon as
 possible and in any event, no later than the business day immediately prior to the date of
 the proposed general meeting referred to above, allot the relevant Shares to the Participant
 credited as fully paid. Subject to the foregoing, upon an order being made or resolution
 passed for the winding up of the Company, all Options and Restricted Shares, to the extent
 unvested and unexercised, shall lapse and become null and void.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.8. For
 the avoidance of doubt, Participants who are granted Awards and/or issued Shares pursuant
 to an Award shall not be parties to, nor shall they be entitled to any rights or benefits
 under any shareholders' agreement or investment agreement entered into amongst the
 shareholders of the Company (as the case may be), except at the written request or with the
 written consent of the Committee (on behalf of the Company) and the shareholders of the Company
 (other than the Participants).

**7.** **TERMS AND CONDITIONS OF OPTIONS** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.1. **Grant of Options**. Under the Plan, the Company may grant an option to subscribe for one or more
 Shares under the Plan ()"**Option** ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.2. **Exercise Price.** The exercise price payable for each Share in respect of which an Option is exercisable
 (the "**Exercise Price**") shall be determined by the Committee from time
 to time, provided that in no event shall the Exercise Price per Share be less than the par
 value of such Share.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.3. **Option Period.** Options shall be exercisable only after vesting. Subject to the provisions of
 this Rule 7, the Options shall be exercisable in whole or in part, before the expiry of 10
 years from the date of grant of the Option, or such other date as may be determined by the
 Committee (the "**Option Period** ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.4. **Acceleration of Options upon Occurrence of Certain Events.** In the event of a change of control in
 the shares of the Company, such as a trade sale, a takeover, any acquisition of a majority
 shareholding interest in the Company by a third party or a compromise or arrangement proposed
 for the purposes of, or in connection with, a scheme for the reconstruction of the Company
 or its amalgamation with another company or companies ()"**Acceleration Events** "),
 the Awards granted to such Participants shall immediately vest and the Committee will, as
 soon as practicable and prior to the completion of such event, procure the allotment or transfer
 to each Participant of the relevant number of Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.5. Notwithstanding
 any other Rule of the Plan, all Awards to the extent unvested and/or unexercised may be accelerated
 at the sole and absolute discretion of the Committee and upon such terms and conditions as
 it deems fit upon the occurrence of certain events.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.6. **Expiry of Options.** Subject to this Rule 7, upon the expiry of the relevant Option Period, the
 corresponding Options shall immediately become null and void. Upon such cancellation, all
 such Options such thereupon immediately lapse without any further claim against the Company
 and the Participants shall have no further rights in respect thereof.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.7. **Exercise of Options.** An Option may be exercised, in whole or in part, by a Participant giving
 notice in writing to the Company in or substantially in the form set out in Schedule B ()"**Exercise Notice** "), subject to such modification as the Committee may from time to time determine,
 accompanied by:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) a
 remittance for the full amount of the aggregate Exercise Price payable in respect of all
 the Shares to be subscribed for upon exercise of the Option to the bank account of the Company,
 details of which shall be notified to the Participant; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) any
 other documentation which the Committee may require in connection with an exercise of the
 Option, including evidence to verify the due execution of the Exercise Notice.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.8. **Delivery of Shares upon exercise of Options.** Subject to the Companies Act of the Cayman Islands
 (as revised) (the "**Companies Act** "), the Company shall have the flexibility
 to deliver the Shares to the Participants upon the exercise of their Options by way of:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) subject
 to applicable laws, the transfer of existing Shares, including any Shares acquired by the
 Company pursuant to a share buy back and/or held by the Company as treasury shares; and/or

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) an
 issue and allotment of new Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.9. **Shares Allotted**. New Shares allotted and issued, and existing Shares procured by the Company
 for transfer, pursuant to the exercise of an Option shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) be
 subject to all the provisions of the Articles of Association of the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) rank
 in full for all entitlements, including dividends or other distributions declared or recommended
 in respect of the then existing Issued Shares in the capital of the Company, save for any
 dividends, rights, allotments or other distributions, the Record Date for which is on or
 after the relevant vesting date. For the purposes of this Rule, "Record Date"
 means the date fixed by the Company for the purposes of determining entitlements to dividends
 or other distributions to or rights of holders of the Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.10. **New Issue of Shares**. An Option does not confer on a Participant any right to participate
 in any new issue of Shares.

**8.** **TERMS AND CONDITIONS OF RESTRICTED SHARES** 

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.1. Restricted
 Shares. The terms and conditions of Share(s) awarded to
 a Participant that are subject to certain restrictions and may be subject to the risk of
 forfeiture are governed by this Rule 8 (" Restricted Shares ").

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.2. Restrictions. At the time of grant, the Committee may, in its sole discretion,
 establish a period of time (a " Restricted Period ")
 and any additional restrictions including the satisfaction of corporate or individual performance
 objectives applicable to an Award of Restricted Shares. Each Award of Restricted Shares may
 be subject to a different Restricted Period and additional restrictions. Restricted Shares
 may not be sold, transferred, assigned, pledged, or otherwise encumbered or disposed of during
 the Restricted Period or prior to the satisfaction of any other applicable restrictions.
 The restrictions may lapse separately or in combination at such times, pursuant to such circumstances,
 in such installments, or otherwise, as the Committee determines at the time of the grant
 of the Award or thereafter.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.3. Forfeiture/Repurchase
 of Restricted Shares. Except as otherwise determined by
 the Committee at the time of the grant of the Award or thereafter, upon the occurrence of
 a Lapsing Event, Restricted Shares that are at that time subject to restrictions shall be
 forfeited or repurchased in accordance with the Letter of Offer.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.4. Removal
 of Restrictions. Except as otherwise determined by the
 Committee at the time of the grant of the Award or thereafter, upon the occurrence of an
 Acceleration Event or Liquidity Event after such Liquidity Notice has been given (together
 with a notice of the existence of the provision of this Rule 8.4), the Committee shall accelerate
 the time at which any restrictions shall lapse or be removed and after the restrictions have
 lapsed, the Participant shall be entitled to hold such shares free from all restrictions,
 and the Shares shall be freely transferable by the Participant, subject to applicable legal
 restrictions.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.5. Notwithstanding
 any other Rule of the Plan, the Committee, in its absolute discretion, may accelerate the
 time at which any restrictions shall lapse or be removed.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.6. Delivery
 of Shares. Upon the expiration or termination of any Restricted
 Period and the satisfaction of any other terms and conditions prescribed by the Committee,
 the restrictions applicable to Restricted Shares shall lapse.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.7. Ranking
 of Shares . New Shares allotted and issued, and existing
 Shares procured by the Company for transfer, on the lapsing of the restrictions applicable
 to Restricted Shares shall:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) be
 subject to all the provisions of the Articles of Association of the Company; and

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) rank
 in full for all entitlements, including dividends or other distributions declared or recommended
 in respect of the then existing Issued Shares in the capital of the Company, save for any
 dividends, rights, allotments or other distributions, the Record Date for which is on or
 after the relevant vesting date. For the purposes of this Rule, "Record Date"
 means the date fixed by the Company for the purposes of determining entitlements to dividends
 or other distributions to or rights of holders of the Shares.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;**9.** **REPURCHASE OR FORFEITURE OF SHARES FROM PARTICIPANT IN THE EVENT OF CESSATION OF EMPLOYMENT OR ENGAGEMENT (AS THE CASE MAY BE)** 

In addition and notwithstanding any other Rule of this Plan, in the event that a Participant ceases to be employed or engaged (as the case may be) by the Company and/or any of its subsidiaries for any reason whatsoever, the Company shall, subject to applicable law, have the right (but not the obligation) to require the Participant to sell and/or procure his nominee(s) (if any) to sell to the Company, or such other party or parties as the Company may direct, all the Shares owned or held by the Participant and/or his nominee(s) (if any) which has been issued to him pursuant to the exercise of the Options or vesting of the Awards granted to him at the same Exercise Price which was paid by the Participant for such Shares (where applicable) or such price as may be specified in the Letter of Offer or by the Committee, and the Participant shall use his best efforts to promptly take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable under applicable laws to effect the transfer of the Shares contemplated under this Rule 9.

**10.** **TERMS OF EMPLOYMENT AND/OR ENGAGEMENT UNAFFECTED** 

The terms of employment and/or engagement (as the case may be) of a Participant shall not be affected by his participation in the Plan, which shall neither form part of such terms nor entitle him to take into account such participation in calculating any compensation or damages on the termination of his employment and/or engagement (as the case may be) for any reason.

**11.** **TAXES** 

All taxes (including income tax) arising from the grant or exercise of any Award granted to any Participant under the Plan shall be borne by that Participant.

**12.** **DISCLAIMER OF LIABILITY** 

Notwithstanding any provisions herein contained and subject to the Companies Act, the Committee and the Company shall not under any circumstances be held liable to any Participant or any other person whomsoever for any costs, losses, expenses and damages whatsoever and howsoever arising in any event, in connection with the Plan or the administration thereof.

**13.** **DISPUTES** 

Any disputes or differences of any nature arising hereunder shall be referred to the Committee and its decision shall be final and binding in all respects.

**14.** **GOVERNING LAW** 

The Plan shall be governed by, and construed in accordance with, the laws of the Republic of Singapore. The Participants, by accepting Awards in accordance with the Plan, and the Company submit to the exclusive jurisdiction of the courts of the Republic of Singapore.

**15.** **CONTRACTS (RIGHTS OF THIRD PARTIES) ACT 2001** 

No person other than the Company or a Participant shall have any right to enforce any provision of the Plan or any Award by virtue of the Contracts (Rights of Third Parties) Act 2001 of Singapore.

**SCHEDULE A-1**

**MHNS EMPLOYEE INCENTIVE PLAN**

**<u>Letter of Offer</u>**

---

| |
|:---|
| **Serial No.:** |
| **Date:** |

---

---

| | |
|:---|:---|
| **To:** | **[Name]** |
|  | [Designation] |
|  | [Address] |

---

***Private and Confidential***

 ****

Dear Sir/Madam,

1. We
 have the pleasure of informing you that, pursuant to the MHNS Employee Incentive Plan (the
 "**Plan** "), you have been nominated to participate in the Plan by the Employee
 Incentive Plan Committee (the "**Committee**") appointed by the Board of Directors
 of Mobile-health Network Solutions (the "**Company**") to administer the Plan.
 Terms as defined in the Plan shall have the same meaning when used in this letter.

2. Accordingly,
 an offer is hereby made to grant you [an option (the "**Option** "), to subscribe
 for and be allotted Shares] / [Restricted Shares] (the "**Award** "), as stipulated
 in the enclosed Acceptance Form in **Annex A**.

3. The
 Award is personal to you and shall not be transferred, charged, pledged, assigned or otherwise
 disposed of by you, in whole or in part, except with the prior approval of the Committee.

4. The
 Award shall be subject to the terms of the Plan, a copy of which is available for inspection
 at the business address of the Company.

5. If
 you wish to accept the offer of the Award on the terms of this letter, please sign and return
 the enclosed Offer Terms and Acceptance Form with a sum of US$______________not later than
 5.00 p.m. on______________, failing which this offer will lapse.

6. [The
 Option granted to you as stipulated in the enclosed Acceptance Form in Annex A shall vest
 and be exercisable upon the [one year] anniversary of your employment with the Company.]
 / [The Restricted Shares granted to you as stipulated in the enclosed Acceptance Form in
 Annex A shall be subject to a Restricted Period of [one year] from the date of your employment
 with the Company.]

Yours faithfully,

Name of Director:

For and on behalf of

**Mobile-health Network Solutions**

Enc.

**SCHEDULE A-2**

**MHNS EMPLOYEE INCENTIVE PLAN**

**<u>Annex A to Letter of Offer</u>**

**Offer Terms and Acceptance Form**

---

| | |
|:---|:---|
| **To:** | **Mobile-health Network Solutions** |
|  | c/o 2 Venture Drive, #07-06/07 |
|  | Vision Exchange, Singapore 608526 |
|  | Attention: The Board of Directors |

---

---

| | |
|:---|:---|
| Closing Date for Acceptance of Offer | : |
| Number of [Restricted] Shares Offered | : |
| Number of [Restricted] Shares Accepted | : |
| Date of Grant of Award | : |

---

1. I
 have read your Letter of Offer dated __________ ()"**Letter of Offer**") and
 agree to be bound by the terms of the Letter of Offer and the Plan referred to therein. Terms
 defined in your Letter of Offer shall have the same meanings when used in this Acceptance
 Form.

2. I
 hereby accept the [option to subscribe for such number Shares ()"**Option** ")]
 / [offer to subscribe for such number of Restricted Shares] as stated above. [I understand
 that I am not obliged to exercise the Option.] I confirm that my acceptance of the Award
 will not result in the contravention of any applicable law or regulation in relation to the
 ownership of shares in the Company or options to subscribe for such shares.

3. I
 agree to keep all information pertaining to the grant of the Award to me confidential. I
 further acknowledge that you have not made any representation to induce me to accept the
 offer and that the terms of the Letter of Offer and this Acceptance Form constitute the entire
 agreement between us relating to the offer.

**Please print in block letters**

---

| | |
|:---|:---|
| Name in full | : |
| Designation | : |
| Address | : |
| Nationality | : |
| NRIC / Passport No. | : |
| Signature | : |
| Date | : |

---

**SCHEDULE B**

**MHNS EMPLOYEE INCENTIVE PLAN**

**<u>Exercise of Option to Subscribe</u>**

---

| | |
|:---|:---|
| **To:** | **Mobile-health Network Solutions** |
|  | c/o 2 Venture Drive, #07-06/07 |
|  | Vision Exchange, Singapore |
|  | 608526 |
|  | Attention: The Board of Directors |

---

 **

***Private and Confidential***

 **

---

| |
|:---|
| Total number of Shares offered and accepted under an Option granted on_________________(Date of Grant) |
| Existing Number of Shares |
| Number of Options to be exercised / Number of Shares **<u>now</u>** to be subscribed |
| Outstanding balance of Shares to be allotted and issued under the Option |
| Exercise Price payable per Share |

---

1. Pursuant to your Letter of
 Offer dated ()"**Letter of Offer**") and my acceptance thereof, I hereby exercise the Option to subscribe for_______________Shares
 in Mobile-health Network Solutions (the "**Company**") at US**$____________** per Share. Terms defined in your Letter
 of Offer shall have the same meanings when used in this Exercise Notice.

2. I
 agree to subscribe for the said Shares subject to the terms of the Letter of Offer, the MHNS
 Employee Incentive Plan and the Articles of Association of the Company.

3. I
 have [remitted / delivered a cheque for / bank draft for / cashier's order for]\* the
 sum of US$________________________being the aggregate consideration for the total amount
 of Shares that I am subscribing for, at a price of US$________________per Share [plus the
 amount of any applicable withholding obligations in connection with this exercise].

4. I
 declare that I am subscribing for the said Shares for myself and not as a nominee for any
 other person.

**Please print in block letters**

---

| | |
|:---|:---|
| Name in full | : |
| Designation | : |
| Address | : |
| Nationality | : |
| NRIC / Passport No. | : |
| Signature | : |
| Date | : |

---

*\* Please delete as appropriate*

## Ex-Filing

?xml version='1.0' encoding='ASCII'? EX-FILING FEES

---

| |
|:---|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Calculation of Filing Fee Tables**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **S-8**  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Mobile-health Network Solutions**  |

---

---

| | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Type**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Security Class Title**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Calculation Rule**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount Registered**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Proposed Maximum Offering Price Per Unit**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Maximum Aggregate Offering Price**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Fee Rate**  | &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Amount of Registration Fee**  |
| 1 | Equity | Ordinary Shares, par value US$0.00016 per share | Other | 521833 | $0.968 | $505134.34 | 0.0001381 | $69.76 |
| Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: | Total Offering Amounts: |  | $505134.34  |  | $69.76  |
| Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  | Total Fee Offsets:  |  |  |  | $0.00  |
| Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  | Net Fee Due:  |  |  |  | $69.76  |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Offering Note** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <sup>1</sup> (1) Represents Mobile-health Network Solutions (the "Registrant")'s Class A ordinary shares, par value US$0.00016 per share ("Class A Ordinary Shares") and Class B ordinary shares, par value US$0.00016 per share ("Class B Ordinary Shares" and, together with the Class A Ordinary Shares, the "Ordinary Shares"). There is no trading market for the Registrant's Class B Ordinary Shares. The Class B Ordinary Shares may be converted into Class A Ordinary Shares according to the terms and provisions of the Registrant's memorandum and articles of association. (2) This registration statement on Form S-8 (this "Registration Statement") registers a maximum aggregate of 521,833 Ordinary Shares of the Registrant issuable pursuant to its MHNS equity incentive plan (the "MHNS Equity Incentive Plan"). In accordance with Rule 416(a) under the Securities Act of 1933, as amended (the "Securities Act"), this Registration Statement also covers an indeterminate number of additional securities which may be offered and issued under the MHNS Equity Incentive Plan to prevent dilution from share splits, share dividends, or similar transactions as provided in the MHNS Equity Incentive Plan. (3) Estimated for the sole purpose of computing the registration fee in accordance with Rule 457(c) and Rule 457(h) under the Securities Act. The price per share and aggregate offering price are based on the average of the high and low prices of the Registrant's Class A Ordinary Shares on February 19, 2026, as reported on NASDAQ

---

| | |
|:---|:---|
| | |
| **Rule 457(p)** | **Rule 457(p)** |
| Fee Offset Claims | N/A |
| Fee Offset Sources | N/A |

---